卡朋特科技 CRS 深 沪
等待开盘 10-08 09:30:00 美东时间
256.25
+4.240
+1.68%
华盛通- 最 高256.675
- 今 开253.48
- 成交量 44.80万股
- 最 低 247.2101
- 昨 收 252.01
- 总市值 127.74亿
- 52周最高 290.64
- 市盈率 静 34.57
- 换手率 0.00%
- 52周最低 138.21
- 委 比 50.00%
- 总股本 4985.01万
- 历史最高 290.64
- 量 比 0.62
- 振 幅 3.76%
- 历史最低 9.20
- 每 手 1
- 风险率 37.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Adicet Bio Shares Initial Safety And Efficacy Data From The First Seven Patients Dosed With ADI-001 In The Ongoing Phase 1 Study In Patients With Autoimmune Diseases
Clinical data to date supports a potentially transformational approach to treating autoimmune diseases with an off-the-shelf, one-time therapy.As of the August 31, 2025 data cut-off date, all seven evaluable LN and SLE
10-07 18:51
Looking Into Carpenter Technology Corp's Recent Short Interest
Carpenter Technology Corp's (NYSE:CRS) short interest as a percent of float has...
10-07 01:01
Caprice Resources Expands Gold Portfolio with Comet Project Acquisition
Caprice Resources Ltd. ( ($AU:CRS) ) has shared an announcement. Caprice Resour...
10-06 08:08
中国通号参建沈白高铁正式开通运营！
9月28日，沈白高铁正式开通运营，这条连接沈阳与长白山、全长430公里的交通大动脉，将为东北全面振兴注入强劲动力。在这条设计时速350公里的高铁背后，中国通号研...
09-29 11:03
Amneal Pharma Submits BLA To FDA For Proposed Biosimilar To XOLAIR, Developed By Kashiv BioSciences
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) ("Amneal" or the "Company") today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for a proposed biosimilar to XOLAIR® (omalizumab), developed by Kashiv BioSciences, LLC.
09-26 20:05
更深缓解、更长生存——诺诚健华明诺凯（坦昔妥单抗）全国首批处方落地
诺诚健华（上交所代码：688428；香港联交所代码：09969）今天宣布，靶向CD19单抗明诺凯（坦昔妥单抗，tafasitamab）近日在北京、上海、广东、黑...
09-25 16:44
European Advisory Panel Recommends Two AstraZeneca Drugs For Approval
AstraZeneca and Amgen secure CHMP support for Tezspire in nasal polyps and Koselugo in neurofibromatosis after strong Phase 3 trial results.
09-23 02:20
In Vivo与Allo CAR-T：谁先攻克商业化堡垒？
（来源：抗体圈） 2020年前后，同种异体CAR-T（AlloCAR-T）疗法风头无两。作为传统自体CAR-T的升级方向，它承诺摆脱“一人一药”的定制化...
09-22 18:46
近期，远大医药(00512.HK)呼吸领域重磅产品切诺®(桉柠蒎肠溶胶囊)斩获国际著名期刊认可
近期，远大医药(00512.HK)呼吸领域重磅产品切诺(桉柠蒎肠溶胶囊)斩获国际著名期刊认可。由复旦大学附属眼耳鼻喉科医院王德辉教授牵头、联合全国13家区域医学中心共同完成的一项关于切诺治疗慢性鼻窦炎(chronic rhinosinusitis，CRS)的多中心临床研究取得重要成果，并在国际著名期刊《International Immunopharmacology》正式在线发表。
09-19 17:50
一波三折后，美“天鹅座”飞船抵达国际空间站“送快递”
【环球时报特约记者 晨阳】美国国家航空航天局（NASA）18日宣布，此前因为提前关闭发动机未能抵达预定轨道的“天鹅座XL”货运飞船经过一系列精心计算的点火动作后...
09-19 06:34
公司简介
公司名称
|
卡朋特科技
|
行业分类
|
金属基件
|
业务描述
|
Carpenter Technology Corp. engages in the manufacturing, fabrication, and distribution of specialty metals. It operates through the Specialty Alloys Operations and Performance Engineered Products segments. The Specialty Alloys Operations segment is composed of its major premium alloy and stainless-steel manufacturing operations. The Performance Engineered Products segment includes the Dynamet titanium, Carpenter Additive, and the Latrobe and Mexico distribution businesses. The company was founded by James Carpenter in 1889 and is headquartered in Philadelphia, PA.
|
Adicet Bio Shares Initial Safety And Efficacy Data From The First Seven Patients Dosed With ADI-001 In The Ongoing Phase 1 Study In Patients With Autoimmune Diseases
Clinical data to date supports a potentially transformational approach to treating autoimmune diseases with an off-the-shelf, one-time therapy.As of the August 31, 2025 data cut-off date, all seven evaluable LN and SLE
10-07 18:51
Looking Into Carpenter Technology Corp's Recent Short Interest
Carpenter Technology Corp's (NYSE:CRS) short interest as a percent of float has...
10-07 01:01
Caprice Resources Expands Gold Portfolio with Comet Project Acquisition
Caprice Resources Ltd. ( ($AU:CRS) ) has shared an announcement. Caprice Resour...
10-06 08:08
中国通号参建沈白高铁正式开通运营！
9月28日，沈白高铁正式开通运营，这条连接沈阳与长白山、全长430公里的交通大动脉，将为东北全面振兴注入强劲动力。在这条设计时速350公里的高铁背后，中国通号研...
09-29 11:03
Amneal Pharma Submits BLA To FDA For Proposed Biosimilar To XOLAIR, Developed By Kashiv BioSciences
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) ("Amneal" or the "Company") today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for a proposed biosimilar to XOLAIR® (omalizumab), developed by Kashiv BioSciences, LLC.
09-26 20:05
更深缓解、更长生存——诺诚健华明诺凯（坦昔妥单抗）全国首批处方落地
诺诚健华（上交所代码：688428；香港联交所代码：09969）今天宣布，靶向CD19单抗明诺凯（坦昔妥单抗，tafasitamab）近日在北京、上海、广东、黑...
09-25 16:44
European Advisory Panel Recommends Two AstraZeneca Drugs For Approval
AstraZeneca and Amgen secure CHMP support for Tezspire in nasal polyps and Koselugo in neurofibromatosis after strong Phase 3 trial results.
09-23 02:20
In Vivo与Allo CAR-T：谁先攻克商业化堡垒？
（来源：抗体圈） 2020年前后，同种异体CAR-T（AlloCAR-T）疗法风头无两。作为传统自体CAR-T的升级方向，它承诺摆脱“一人一药”的定制化...
09-22 18:46
近期，远大医药(00512.HK)呼吸领域重磅产品切诺®(桉柠蒎肠溶胶囊)斩获国际著名期刊认可
近期，远大医药(00512.HK)呼吸领域重磅产品切诺(桉柠蒎肠溶胶囊)斩获国际著名期刊认可。由复旦大学附属眼耳鼻喉科医院王德辉教授牵头、联合全国13家区域医学中心共同完成的一项关于切诺治疗慢性鼻窦炎(chronic rhinosinusitis，CRS)的多中心临床研究取得重要成果，并在国际著名期刊《International Immunopharmacology》正式在线发表。
09-19 17:50
一波三折后，美“天鹅座”飞船抵达国际空间站“送快递”
【环球时报特约记者 晨阳】美国国家航空航天局（NASA）18日宣布，此前因为提前关闭发动机未能抵达预定轨道的“天鹅座XL”货运飞船经过一系列精心计算的点火动作后...
09-19 06:34
派息除权日
|
每股总股息
| 派息日期 |
2025-08-26
|
0.20
|
2025-09-04
|
2025-04-22
|
0.20
|
2025-06-05
|
2025-01-28
|
0.20
|
2025-03-06
|
2024-10-22
|
0.20
|
2024-12-05
|
2024-08-27
|
0.20
|
2024-09-05
|
2024-04-22
|
0.20
|
2024-06-06
|
2024-01-29
|
0.20
|
2024-03-07
|
2023-10-23
|
0.20
|
2023-12-07
|
2023-08-21
|
0.20
|
2023-09-07
|
2023-05-01
|
0.20
|
2023-06-01
|
2023-01-30
|
0.20
|
2023-03-02
|
2022-10-24
|
0.20
|
2022-12-01
|
2022-08-22
|
0.20
|
2022-09-01
|
2022-05-02
|
0.20
|
2022-06-02
|
2022-01-31
|
0.20
|
2022-03-03
|
2021-10-25
|
0.20
|
2021-12-02
|
2021-08-30
|
0.20
|
2021-09-07
|
2021-05-03
|
0.20
|
2021-06-03
|
2021-02-01
|
0.20
|
2021-03-04
|
2020-10-26
|
0.20
|
2020-12-03
|
2020-08-24
|
0.20
|
2020-09-03
|
2020-05-04
|
0.20
|
2020-06-04
|
2020-01-31
|
0.20
|
2020-03-05
|
2019-10-21
|
0.20
|
2019-12-05
|
2019-08-26
|
0.20
|
2019-09-05
|
2019-04-29
|
0.20
|
2019-06-06
|
2019-02-04
|
0.20
|
2019-03-07
|
2018-10-22
|
0.20
|
2018-12-06
|
2018-08-27
|
0.20
|
2018-09-06
|
2018-04-30
|
0.18
|
2018-06-07
|
2018-02-05
|
0.18
|
2018-03-01
|
2017-10-23
|
0.18
|
2017-12-07
|
2017-08-18
|
0.18
|
2017-09-07
|
2017-04-28
|
0.18
|
2017-06-01
|
2017-02-03
|
0.18
|
2017-03-02
|
2016-10-21
|
0.18
|
2016-12-01
|
2016-08-19
|
0.18
|
2016-09-01
|
2016-04-29
|
0.18
|
2016-06-02
|
2016-02-05
|
0.18
|
2016-03-03
|
2015-10-23
|
0.18
|
2015-12-03
|
2015-09-03
|
0.18
|
2015-09-15
|
2015-05-08
|
0.18
|
2015-06-04
|
2015-02-06
|
0.18
|
2015-03-05
|
2014-10-24
|
0.18
|
2014-12-04
|
2014-08-22
|
0.18
|
2014-09-05
|
2014-05-09
|
0.18
|
2014-06-05
|
2014-02-07
|
0.18
|
2014-03-06
|
2013-10-25
|
0.18
|
2013-12-05
|
2013-08-23
|
0.18
|
2013-09-06
|
2013-05-10
|
0.18
|
2013-06-06
|
2013-02-08
|
0.18
|
2013-03-07
|
2012-10-19
|
0.18
|
2012-12-06
|
2012-08-24
|
0.18
|
2012-09-07
|
2012-04-27
|
0.18
|
2012-06-07
|
2012-01-27
|
0.18
|
2012-03-01
|
2011-10-21
|
0.18
|
2011-12-01
|
2011-08-26
|
0.18
|
2011-09-02
|
2011-04-29
|
0.18
|
2011-06-02
|
2011-01-28
|
0.18
|
2011-03-03
|
2010-10-22
|
0.18
|
2010-12-02
|
2010-08-27
|
0.18
|
2010-09-03
|
2010-04-29
|
0.18
|
2010-06-03
|
2010-01-29
|
0.18
|
2010-03-04
|
2009-10-23
|
0.18
|
2009-12-03
|
2009-08-28
|
0.18
|
2009-09-04
|
2009-05-01
|
0.18
|
2009-06-04
|
2009-01-30
|
0.18
|
2009-03-05
|
2008-10-24
|
0.18
|
2008-12-04
|
2008-08-28
|
0.18
|
2008-09-05
|
2008-05-02
|
0.18
|
2008-06-05
|
2008-02-01
|
0.15
|
2008-03-06
|
2007-10-26
|
0.30
|
2007-12-06
|
2007-08-30
|
0.30
|
2007-09-07
|
2007-05-04
|
0.30
|
2007-06-07
|
2007-02-02
|
0.22
|
2007-03-01
|
2006-10-27
|
0.22
|
2006-12-07
|
2006-08-31
|
0.22
|
2006-09-08
|
2006-05-05
|
0.15
|
2006-06-01
|
2006-02-03
|
0.15
|
2006-03-02
|
2005-11-04
|
0.15
|
2005-12-01
|
2005-08-26
|
0.15
|
2005-09-02
|
2005-05-06
|
0.13
|
2005-06-02
|
2005-02-04
|
0.10
|
2005-03-03
|
2004-11-05
|
0.10
|
2004-12-02
|
2004-08-27
|
0.08
|
2004-09-03
|
2004-04-30
|
0.08
|
2004-06-03
|
2004-01-30
|
0.08
|
2004-03-04
|
2003-11-05
|
0.08
|
2003-12-04
|
2003-08-28
|
0.08
|
2003-09-05
|
2003-05-02
|
0.08
|
2003-06-05
|
2003-01-31
|
0.08
|
2003-03-06
|
2002-11-05
|
0.08
|
2002-12-05
|
2002-08-29
|
0.33
|
2002-09-06
|
2002-05-03
|
0.33
|
2002-06-06
|
2002-02-01
|
0.33
|
2002-03-07
|
2001-10-30
|
0.33
|
2001-12-06
|
2001-08-24
|
0.33
|
2001-09-06
|
2001-05-04
|
0.33
|
2001-06-07
|
2001-02-02
|
0.33
|
2001-03-01
|
2000-10-31
|
0.33
|
2000-12-07
|
2000-08-25
|
0.33
|
2000-09-07
|
2000-04-28
|
0.33
|
2000-06-01
|
2000-02-04
|
0.33
|
2000-03-02
|
1999-11-02
|
0.33
|
1999-12-02
|
1999-08-20
|
0.33
|
1999-09-02
|
1999-04-30
|
0.33
|
1999-06-03
|
1999-02-03
|
0.33
|
1999-03-04
|
1998-11-03
|
0.33
|
1998-12-03
|
1998-08-14
|
0.33
|
1998-09-03
|
1998-05-01
|
0.33
|
1998-06-04
|
1998-01-28
|
0.33
|
1998-03-05
|
1997-10-28
|
0.33
|
1997-12-04
|
1997-08-15
|
0.33
|
1997-09-04
|
1997-05-02
|
0.33
|
1997-06-05
|
1997-01-29
|
0.33
|
1997-03-06
|
1996-10-29
|
0.33
|
1996-12-05
|
1996-08-16
|
0.33
|
1996-09-05
|
1996-05-01
|
0.33
|
1996-06-06
|
1996-01-30
|
0.33
|
1996-03-07
|
1995-10-31
|
0.33
|
1995-12-07
|
1995-08-18
|
0.66
|
1995-09-07
|
1995-05-01
|
0.60
|
1995-06-01
|
1995-01-27
|
0.60
|
1995-03-02
|
1994-10-28
|
0.60
|
1994-12-01
|
1994-08-17
|
0.60
|
1994-09-01
|
1994-05-02
|
0.60
|
1994-06-02
|
1994-01-28
|
0.60
|
1994-03-03
|
1993-10-29
|
0.60
|
1993-12-02
|
1993-08-18
|
0.60
|
1993-09-02
|
1993-05-03
|
0.60
|
1993-06-03
|
1993-02-01
|
0.60
|
1993-03-04
|
1992-11-02
|
0.60
|
1992-12-03
|
1992-08-19
|
0.60
|
1992-09-03
|
1992-05-04
|
0.60
|
1992-06-04
|
1992-02-03
|
0.60
|
1992-03-05
|
1991-11-04
|
0.60
|
1991-12-05
|
1991-08-14
|
0.60
|
1991-09-05
|
1991-05-06
|
0.60
|
1991-06-06
|
1991-02-04
|
0.60
|
1991-03-07
|
1990-11-05
|
0.60
|
1990-12-06
|
1990-08-15
|
0.60
|
1990-09-06
|
1990-04-30
|
0.60
|
1990-06-07
|
1990-02-13
|
0.60
|
1990-03-01
|
1989-11-14
|
0.60
|
1989-12-07
|
1989-08-17
|
0.52
|
1989-09-07
|
1989-05-18
|
0.52
|
1989-06-01
|
1989-02-19
|
0.52
|
1987-03-05
|
1989-02-15
|
0.52
|
1989-03-02
|
1988-11-15
|
0.52
|
1988-12-01
|
1988-08-18
|
0.52
|
1988-09-01
|
1988-05-19
|
0.52
|
1988-06-02
|
1988-02-18
|
0.52
|
1988-03-03
|
1987-11-06
|
0.52
|
1987-12-03
|
1987-08-20
|
0.52
|
1987-09-03
|
1987-02-19
|
0.52
|
1987-03-05
|
1986-11-12
|
0.52
|
1986-12-04
|
1986-08-21
|
0.52
|
1986-09-04
|
1986-05-15
|
0.52
|
1986-06-05
|
1986-02-20
|
0.52
|
1986-03-06
|
1985-11-13
|
0.52
|
1985-12-05
|
1985-08-15
|
0.52
|
1985-09-05
|
1985-05-16
|
0.52
|
1985-06-06
|
1985-02-20
|
0.52
|
1985-03-07
|
1984-11-14
|
0.52
|
1984-12-06
|
1984-08-16
|
0.52
|
1984-09-06
|
1984-05-17
|
0.52
|
1984-06-07
|
1984-02-14
|
0.52
|
1984-03-01
|
1983-11-14
|
0.52
|
1983-12-01
|
1983-08-17
|
0.52
|
1983-09-01
|
1983-05-18
|
0.52
|
1983-06-02
|
1983-02-16
|
0.52
|
1983-03-03
|
1982-11-12
|
0.52
|
1982-12-02
|
1982-08-18
|
0.52
|
1982-09-02
|
1982-05-19
|
0.52
|
1982-06-03
|
1982-02-18
|
0.52
|
1982-03-04
|
1981-11-13
|
0.52
|
1981-12-03
|
1981-08-19
|
0.52
|
1981-09-03
|
1981-05-19
|
0.50
|
1981-06-04
|
1981-02-19
|
0.50
|
1981-03-05
|
1980-11-14
|
0.50
|
1980-12-04
|
1980-08-21
|
0.50
|
1980-09-04
|
1980-05-15
|
0.47
|
1980-06-05
|
1980-02-20
|
0.47
|
1980-03-05
|
1979-11-19
|
0.47
|
1979-12-05
|
1979-08-21
|
0.47
|
1979-09-05
|
1979-05-21
|
0.40
|
1979-06-06
|
1979-02-12
|
0.40
|
1979-02-28
|
1978-11-20
|
0.40
|
1978-12-06
|
1978-08-21
|
0.40
|
1978-09-06
|
1978-05-16
|
0.30
|
1978-05-31
|
1978-02-13
|
0.30
|
1978-03-01
|
1977-11-14
|
0.30
|
1977-11-30
|
1977-08-16
|
0.60
|
1977-08-31
|
1977-05-17
|
0.50
|
1977-06-01
|
